BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8233545)

  • 1. Spinal cord morphology and antinociception after chronic intrathecal administration of excitatory amino acid antagonists in the rat.
    Kristensen JD; Post C; Gordh T; Svensson BA
    Pain; 1993 Sep; 54(3):309-316. PubMed ID: 8233545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The NMDA antagonist 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid (CPP) has antinociceptive effect after intrathecal injection in the rat.
    Kristensen JD; Karlsten R; Gordh T; Berge OG
    Pain; 1994 Jan; 56(1):59-67. PubMed ID: 8159442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The intrathecal administration of excitatory amino acid receptor antagonists selectively attenuated carrageenan-induced behavioral hyperalgesia in rats.
    Ren K; Williams GM; Hylden JL; Ruda MA; Dubner R
    Eur J Pharmacol; 1992 Aug; 219(2):235-43. PubMed ID: 1358641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antinociceptive actions of different classes of excitatory amino acid receptor antagonists in mice.
    Näsström J; Karlsson U; Post C
    Eur J Pharmacol; 1992 Feb; 212(1):21-9. PubMed ID: 1313371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathecal oxymetazoline does not produce neurotoxicity in the spinal cord of the rat.
    Loomis CW; Vyas D; Sherman SE
    Brain Res; 1992 Dec; 599(1):73-82. PubMed ID: 1283563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laser-Doppler evaluation of spinal cord blood flow after intrathecal administration of an N-methyl-D-aspartate antagonist in rats.
    Kristensen JD; Karlsten R; Gordh T
    Anesth Analg; 1994 May; 78(5):925-31. PubMed ID: 8160992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spinal cord blood flow after intrathecal injection of a N-methyl-D-aspartate receptor antagonist or an adenosine receptor agonist in rats.
    Kristensen JD; Karlsten R; Gordh T; Holtz A
    Anesth Analg; 1993 Jun; 76(6):1279-83. PubMed ID: 8498666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spinal antinociceptive effects of excitatory amino acid antagonists: quisqualate modulates the action of N-methyl-D-aspartate.
    Raigorodsky G; Urca G
    Eur J Pharmacol; 1990 Jun; 182(1):37-47. PubMed ID: 1976097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective depression of the spinal polysynaptic reflex by the NMDA receptor antagonists in an isolated spinal cord in vitro.
    Maruoka Y; Ohno Y; Tanaka H; Yasuda H; Ohtani K; Sakamoto H; Kawabe A; Tamamura C; Nakamura M
    Gen Pharmacol; 1997 Oct; 29(4):645-9. PubMed ID: 9352316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the NMDA-antagonist, MK 801, on benzodiazepine-opioid interactions at the spinal and supraspinal level in rats.
    Luger TJ; Lorenz IH; Grabner-Weiss C; Hayashi T
    Br J Pharmacol; 1995 Mar; 114(5):1097-103. PubMed ID: 7780645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors.
    Wong CS; Cherng CH; Luk HN; Ho ST; Tung CS
    Eur J Pharmacol; 1996 Feb; 297(1-2):27-33. PubMed ID: 8851162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The loss of antinociceptive efficacy of spinal morphine in rats with nerve ligation injury is prevented by reducing spinal afferent drive.
    Ossipov MH; Lopez Y; Nichols ML; Bian D; Porreca F
    Neurosci Lett; 1995 Oct; 199(2):87-90. PubMed ID: 8584250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the antinociception produced by intrathecally administered muscarinic agonists in rats.
    Iwamoto ET; Marion L
    J Pharmacol Exp Ther; 1993 Jul; 266(1):329-38. PubMed ID: 8101218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Actions of 4-amino-3-(5-methoxybenzo(b)furan-2-yl) butanoic acid and 4-amino-3-benzo(b)furan-2-yl butanoic acid in the rat spinal cord.
    Hammond DL; Moy ML
    Eur J Pharmacol; 1992 Dec; 229(2-3):227-34. PubMed ID: 1337047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the development of tolerance and potential spinal neurotoxicity after chronic intrathecal carbachol-antinociception in the rat.
    Svensson BA; Sottile A; Gordh T
    Acta Anaesthesiol Scand; 1991 Feb; 35(2):141-7. PubMed ID: 2024563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of nitric oxide synthase isoforms in the dorsal horn of monoarthritic rats: effects of competitive and uncompetitive N-methyl-D-aspartate antagonists.
    Infante C; Díaz M; Hernández A; Constandil L; Pelissier T
    Arthritis Res Ther; 2007; 9(3):R53. PubMed ID: 17521446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the Effects of L-4-Chlorokynurenine on Nociception in Rodents.
    Yaksh TL; Schwarcz R; Snodgrass HR
    J Pain; 2017 Oct; 18(10):1184-1196. PubMed ID: 28428091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of NMDA receptors in the nucleus accumbens elicits spontaneous tail-flicks in rats.
    Millan MJ; Audinot V; Honoré P; Bervoets K; Veiga S; Brocco M
    Eur J Pharmacol; 2000 Jan; 388(1):37-47. PubMed ID: 10657545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of NMDA and group I mGluR antagonists on both nociception and spinal cord protein kinase C translocation in the formalin test and a model of neuropathic pain in rats.
    Yashpal K; Fisher K; Chabot JG; Coderre TJ
    Pain; 2001 Oct; 94(1):17-29. PubMed ID: 11576741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of spinal opioid antinociception by intrathecal beta-endorphin1-27 in the rat.
    Hong M; Sutak M; Jhamandas K
    Br J Pharmacol; 1993 Apr; 108(4):1137-42. PubMed ID: 8485623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.